Physician profile
Robert Easley
NPI 1407329592
$2,118.72
in general payments reported to CMS, 2019-2025
18 companies · $803 in 2025
The $803 reported for 2025 was more than what 98% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $180 · 2022: $331 · 2023: $410 · 2024: $395 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,608.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $754.42 | 2021-2025 | Entyvio, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $388.81 | 2021-2025 | Xifaxan |
| Regeneron Healthcare Solutions, INC. | $198.22 | 2022-2025 | Dupixent |
| Janssen Biotech, INC. | $172.75 | 2023-2025 | Tremfya, Stelara, Remicade |
| Merck Sharp & Dohme LLC | $144.38 | 2021-2024 | Dificid, Zinplava |
| Ardelyx, INC. | $124.62 | 2022-2025 | Ibsrela |
| Lilly USA, LLC | $58.03 | 2025 | Omvoh |
| Mallinckrodt Hospital Products INC. | $48.13 | 2024-2025 | Terlivaz |
| Nestle Healthcare Nutrition INC. | $45.65 | 2022 | |
| Redhill Biopharma INC. | $43.72 | 2021-2022 | |
| Edwards Lifesciences Corporation | $28.87 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.27 | 2023 | Zeposia |
| Madrigal Pharmaceuticals | $19.75 | 2024 | Resmetirom |
| Braintree Laboratories, INC. | $18.51 | 2023 | Suflave |
| Intercept Pharmaceuticals, INC. | $16.94 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $16.88 | 2024 | |
| Celltrion USA INC. | $13.94 | 2025 | Vegzelma |
| Micro-Tech Endoscopy USA, INC. | $4.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Easley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.